Evidence map›Paper›PMID 32244274›Full record

ArticleJournal of clinical medicine2020

The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study.

Joris C Verster, Thomas A Dahl, Andrew Scholey, Jacqueline M Iversen

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Clinical Evaluation ofFoods (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Turmeric extract (Heliyon · 2022
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Joris C VersterDivision of Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584CG Utrecht, The Netherlands.ORCID 0000-0002-6455-2096
Thomas A DahlSen-Jam Pharmaceutical, 223 Wall St., #130, Huntington, NY 11743, USA.
Andrew ScholeyCentre for Human Psychopharmacology, Swinburne University, Melbourne VIC 3122, Australia.ORCID 0000-0003-4484-5462
Jacqueline M IversenSen-Jam Pharmaceutical, 223 Wall St., #130, Huntington, NY 11743, USA.
Swinburne University of Technology · AUUtrecht University · NL

Funding

Sen-Jam Pharmaceutical not applicable
6 · The paper itself

Abstract

backgroundDespite a clear market need and many hangover products available, currently there is no hangover treatment that is supported by substantial scientific evidence demonstrating its efficacy and safety. A pilot study was conducted to investigate the effects of a potential new hangover treatment, SJP-001, and its constituents (220 mg naproxen and 60 mg fexofenadine) on hangover severity.

methods

resultsDISCUSSION: Compared to placebo, SJP-001 significantly reduced overall hangover severity. The effects of SJP-001 should be further examined in a double-blind, placebo-controlled trial with a larger sample size and controlled administration of sufficient amounts of alcohol to provoke a more substantial alcohol hangover.

Indexed as

alcoholfexofenadinehangovernaproxenpreventionSJP-001treatment

Identifiers

PMID32244274
PMCPMC7230243
OpenAlexW3013034094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.